LPL Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163M Sell
325,602
-11,673
-3% -$5.6M 0.04% 461
2026
Q1
$166M Buy
337,275
+4,283
+1% +$2.32M 0.04% 396
2025
Q4
$193M Buy
332,992
+27,617
+9% +$15.6M 0.05% 336
2025
Q3
$148M Buy
305,375
+24,151
+9% +$11.2M 0.04% 396
2025
Q2
$114M Buy
281,224
+2,925
+1% +$1.22M 0.04% 431
2025
Q1
$138M Buy
278,299
+15,862
+6% +$8.59M 0.05% 325
2024
Q4
$137M Buy
262,437
+25,593
+11% +$14.1M 0.06% 302
2024
Q3
$147M Buy
236,844
+19,074
+9% +$11.3M 0.07% 266
2024
Q2
$120M Buy
217,770
+9,578
+5% +$5.49M 0.06% 283
2024
Q1
$121M Sell
208,192
-41,486
-17% -$23.3M 0.07% 264
2023
Q4
$133M Buy
249,678
+15,318
+7% +$7.41M 0.08% 218
2023
Q3
$119M Buy
234,360
+16,021
+7% +$8.54M 0.08% 215
2023
Q2
$114M Buy
218,339
+11,162
+5% +$6.02M 0.08% 226
2023
Q1
$119M Buy
207,177
+3,328
+2% +$1.88M 0.09% 198
2022
Q4
$112M Buy
203,849
+965
+0.5% +$511K 0.1% 200
2022
Q3
$103M Buy
202,884
+7,724
+4% +$4.32M 0.1% 186
2022
Q2
$106M Buy
195,160
+10,647
+6% +$5.86M 0.1% 189
2022
Q1
$109M Buy
184,513
+10,896
+6% +$6.26M 0.09% 200
2021
Q4
$116M Buy
173,617
+11,160
+7% +$6.97M 0.1% 193
2021
Q3
$92.8M Buy
162,457
+13,244
+9% +$7.27M 0.09% 222
2021
Q2
$75.3M Buy
149,213
+7,160
+5% +$3.38M 0.08% 240
2021
Q1
$64.8M Buy
142,053
+9,963
+8% +$4.76M 0.07% 247
2020
Q4
$61.5M Buy
132,090
+13,674
+12% +$6.41M 0.08% 234
2020
Q3
$52.3M Buy
118,416
+14,537
+14% +$6.01M 0.08% 230
2020
Q2
$37.6M Buy
103,879
+3,690
+4% +$1.24M 0.07% 257
2020
Q1
$28.4M Buy
100,189
+10,630
+12% +$3.35M 0.06% 249
2019
Q4
$29.1M Buy
89,559
+2,578
+3% +$782K 0.05% 284
2019
Q3
$25.3M Buy
86,981
+5,588
+7% +$1.6M 0.05% 284
2019
Q2
$23.9M Buy
81,393
+3,426
+4% +$944K 0.05% 289
2019
Q1
$21.3M Buy
77,967
+5,464
+8% +$1.36M 0.05% 298
2018
Q4
$16.2M Buy
72,503
+5,355
+8% +$1.26M 0.04% 318
2018
Q3
$16.4M Buy
67,148
+650
+1% +$150K 0.04% 341
2018
Q2
$13.8M Buy
66,498
+4,399
+7% +$934K 0.04% 364
2018
Q1
$12.8M Buy
62,099
+4,883
+9% +$1.02M 0.04% 380
2017
Q4
$10.9M Buy
57,216
+2,910
+5% +$557K 0.03% 399
2017
Q3
$10.3M Buy
54,306
+2,473
+5% +$448K 0.04% 373
2017
Q2
$9.04M Buy
51,833
+16,418
+46% +$2.76M 0.03% 384
2017
Q1
$5.47M Sell
35,415
-447
-1% -$68.3K 0.04% 394
2016
Q4
$5.15M Sell
35,862
-464
-1% -$68.4K 0.04% 399
2016
Q3
$5.72M Sell
36,326
-684
-2% -$105K 0.05% 337
2016
Q2
$5.52M Sell
37,010
-27,264
-42% -$4.02M 0.05% 340
2016
Q1
$9.09M Sell
64,274
-4,775
-7% -$640K 0.03% 470
2015
Q4
$9.57M Buy
69,049
+12,573
+22% +$1.68M 0.03% 460
2015
Q3
$7.15M Sell
56,476
-595
-1% -$77.5K 0.04% 359
2015
Q2
$7.44M Sell
57,071
-1,324
-2% -$173K 0.04% 391
2015
Q1
$7.71M Buy
58,395
+592
+1% +$76.3K 0.04% 367
2014
Q4
$7.24M Sell
57,803
-1,823
-3% -$222K 0.04% 361
2014
Q3
$7.13M Buy
59,626
+6,393
+12% +$777K 0.04% 346
2014
Q2
$6.28M Sell
53,233
-576
-1% -$67.8K 0.04% 390
2014
Q1
$6.47M Sell
53,809
-2,681
-5% -$319K 0.04% 373
2013
Q4
$6.29M Buy
56,490
+2,084
+4% +$207K 0.04% 385
2013
Q3
$5.04M Buy
54,406
+7,715
+17% +$698K 0.03% 414
2013
Q2
$3.95M Buy
+46,691
New +$3.89M 0.03% 452

Other funds holding TMO

LPL Financial's TMO Position: Q2 2026 in Review

LPL Financial reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, selling an estimated $5.6M and leaving 325,602 shares worth $163M. The position accounts for 0.04% of the portfolio, ranked #461.

LPL Financial first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $193M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LPL Financial held 325,602 shares of Thermo Fisher Scientific worth $163M as of Q2 2026.
  • LPL Financial sold 11,673 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.6M.
  • Thermo Fisher Scientific made up 0.04% of LPL Financial's portfolio in Q2 2026, its #461 holding.
  • LPL Financial first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Thermo Fisher Scientific position peaked at $193M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.